Skip to main content

Table 4 ORs and 95% Cls for quartiles of dietary nutrients intake with cervical intraepithelial neoplasia grade1 risk among 2304 women in the studya

From: Dietary nutrient intake related to higher grade cervical intraepithelial neoplasia risk: a Chinese population-based study

 

Quartiles of dietary nutrientsb

Q1

Q2

Q3

Q4

P-trendc

Folate

     

 Median intake (μg/day)

297

381

488

764

 

 No. of cases

132

147

139

146

 

 Model 1

0.91 (0.69–1.20)

1.01 (0.77–1.32)

0.91 (0.69–1.19)

1.00 (reference)

< 0.001

 Model 2

0.95 (0.72–1.26)

1.04 (0.79–1.37)

0.92 (0.70–1.21)

1.00 (reference)

0.012

 Model 3

0.96 (0.72–1.27)

1.04 (0.79–1.37)

0.91 (0.69–1.21)

1.00 (reference)

0.020

Vitamin B1

     

 Median intake (mg/day)

1.1

1.4

1.9

2.7

 

 No. of cases

134

157

132

141

 

 Model 1

0.91 (0.68–1.22)

1.25 (0.95–1.65)

0.89 (0.68–1.15)

1.00 (reference)

< 0.001

 Model 2

0.98 (0.73–1.31)

1.31 (0.99–1.74)

0.89 (0.68–1.17)

1.00 (reference)

0.011

 Model 3

0.99 (0.74–1.34)

1.33 (1.00–1.77)

0.91 (0.69–1.19)

1.00 (reference)

0.017

Vitamin B2

     

 Median intake (mg/day)

1.1

1.4

1.8

2.7

 

 No. of cases

123

148

157

136

 

 Model 1

0.85 (0.64–1.12)

1.13 (0.85–1.48)

1.08 (0.82–1.42)

1.00 (reference)

< 0.001

 Model 2

0.88 (0.66–1.17)

1.16 (0.88–1.54)

1.09 (0.83–1.44)

1.00 (reference)

0.011

 Model 3

0.87 (0.66–1.17)

1.15 (0.86–1.52)

1.10 (0.83–1.45)

1.00 (reference)

0.020

Vitamin B6

     

 Median intake (mg/day)

1.7

2.1

2.6

3.9

 

 No. of cases

144

146

131

143

 

 Model 1

1.04 (0.79–1.36)

0.99 (0.76–1.30)

0.90 (0.69–1.19)

1.00 (reference)

< 0.001

 Model 2

1.08 (0.82–1.43)

1.00 (0.76–1.32)

0.90 (0.68–1.19)

1.00 (reference)

< 0.001

 Model 3

1.09 (0.83–1.44)

0.99 (0.75–1.31)

0.91 (0.69–1.21)

1.00 (reference)

0.019

Vitamin C

     

 Median intake (mg/day)

46.0

62.8

86.9

138.9

 

 No. of cases

124

149

145

146

 

 Model 1

0.85 (0.65–1.13)

1.05 (0.81–1.38)

1.01 (0.77–1.33)

1.00 (reference)

< 0.001

 Model 2

0.87 (0.65–1.16)

1.09 (0.83–1.44)

1.04 (0.79–1.36)

1.00 (reference)

0.012

 Model 3

0.86 (0.65–1.15)

1.09 (0.83–1.44)

1.04 (0.79–1.37)

1.00 (reference)

0.021

Vitamin E

     

 Median intake (mg/day)

4.4

8.8

10.8

21.7

 

 No. of cases

131

135

151

147

 

 Model 1

0.83 (0.63–1.09)

0.86 (0.65–1.13)

1.08 (0.83–1.42)

1.00 (reference)

< 0.001

 Model 2

0.84 (0.63–1.11)

0.88 (0.67–1.16)

1.09 (0.83–1.44)

1.00 (reference)

0.013

 Model 3

0.85 (0.64–1.12)

0.87 (0.66–1.16)

1.10 (0.83–1.45)

1.00 (reference)

0.023

Vitamin K

     

 Median intake (μg/day)

133.0

194.0

285.0

534.0

 

 No. of cases

125

159

139

141

 

 Model 1

0.94 (0.71–1.23)

1.23 (0.93–1.62)

1.00 (0.77–1.31)

1.00 (reference)

< 0.001

 Model 2

0.96 (0.73–1.27)

1.24 (0.94–1.64)

1.01 (0.77–1.33)

1.00 (reference)

0.010

 Model 3

0.98 (0.74–1.29)

1.24 (0.94–1.65)

1.03 (0.79–1.36)

1.00 (reference)

0.017

Niacin

     

 Median intake (mg/day)

17.7

21.6

27.9

42.8

 

 No. of cases

147

140

135

142

 

 Model 1

1.11 (0.84–1.46)

0.96 (0.73–1.27)

0.96 (0.73–1.26)

1.00 (reference)

< 0.001

 Model 2

1.14 (0.86–1.51)

0.97 (0.74–1.28)

0.93 (0.71–1.23)

1.00 (reference)

0.012

 Model 3

1.15 (0.87–1.53)

0.96 (0.73–1.26)

0.94 (0.72–1.25)

1.00 (reference)

0.020

Dietary fiber

     

 Median intake (g/day)

27.4

34.5

43.7

63.2

 

 No. of cases

138

148

136

142

 

 Model 1

0.99 (0.75–1.30)

1.07 (0.82–1.41)

0.92 (0.70–1.21)

1.00 (reference)

< 0.001

 Model 2

1.05 (0.79–1.39)

1.12 (0.85–1.47)

0.93 (0.71–1.23)

1.00 (reference)

0.010

 Model 3

1.05 (0.79–1.39)

1.12 (0.85–1.48)

0.95 (0.72–1.25)

1.00 (reference)

0.018

  1. CIN1, cervical intraepithelial neoplasia grade 1; CI, confidence interval
  2. aValues are n or ORs (95% CIs) obtained from logistic regression analysis, based on the highest intake group as the reference, unless otherwise indicated
  3. bModel 1: odds ratios unadjusted; Model 2: odds ratios adjusted for age, education years, annual family salary, smoker, age at menarche, menopause status, IUD use, years of IUD use, Sexual activity in menstrual period, had gynecologic surgery, had vaginitis; Model 3: additionally odds ratios adjusted for high-risk HPV, SCJ visibility, vaginal pH
  4. cP values for differences between groups were obtained from the Bonferroni correction test for categoric variables